CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

Patrick J. Hanley, Jan J. Melenhorst, Sarah Nikiforow, Phillip Scheinberg, James W. Blaney, Gail Demmler-Harrison, C. Russell Cruz, Sharon Lam, Robert A. Krance, Kathryn S. Leung, Caridad A. Martinez, Hao Liu, Daniel C. Douek, Helen E. Heslop, Cliona M. Rooney, Elizabeth J. Shpall, A. John Barrett, Catherine M. Bollard

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Adoptive transfer of cytomegalovirus (CMV)-specific T cells derived from adult seropositive donors can effectively restore antiviral immunity after transplantation. However, CMV-seronegative donors lack CMV-specific memory T cells, which restricts the availability of virus-specific T cells for immunoprophylaxis. We demonstrate the feasibility of deriving CMV-specific T cells from naïve cells for T cell therapy. Naïve T cells primed to recognize CMV were restricted to different, atypical epitopes than T cells derived from CMV-seropositive individuals; however, these two cell populations had similar avidities. CMV-seropositive individuals also had T cells recognizing these atypical epitopes, but these cells had a lower avidity than those derived from the seronegative subjects, which suggests that high-avidity T cells to these epitopes may be lost over time. Indeed, recipients of cord blood (CB) grafts who did not develop CMV were found by clonotypic analysis to have T cells recognizing atypical CMVpp65 epitopes. Therefore, we examined unmanipulated CB units and found that T cells with T cell receptors restricted by atypical epitopes were the most common, which may explain why these T cells expanded. When infused to recipients, naïve donor-derived virus-specific T cells that recognized atypical epitopes were associated with prolonged periods of CMV-free survival and complete remission. These data suggest that naïve-derived T cells from seronegative patients may be an additional source of cells for CMV immunoprophylaxis.

Original languageEnglish (US)
Article number285ra63
JournalScience Translational Medicine
Volume7
Issue number285
DOIs
StatePublished - Apr 29 2015
Externally publishedYes

Fingerprint

Cytomegalovirus
Epitopes
T-Lymphocytes
T-Lymphocyte Epitopes
Tissue Donors
Fetal Blood
Viruses
Adoptive Transfer
Cell- and Tissue-Based Therapy
T-Cell Antigen Receptor
Antiviral Agents
Immunity
Transplantation
Transplants

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hanley, P. J., Melenhorst, J. J., Nikiforow, S., Scheinberg, P., Blaney, J. W., Demmler-Harrison, G., ... Bollard, C. M. (2015). CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Science Translational Medicine, 7(285), [285ra63]. https://doi.org/10.1126/scitranslmed.aaa2546

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. / Hanley, Patrick J.; Melenhorst, Jan J.; Nikiforow, Sarah; Scheinberg, Phillip; Blaney, James W.; Demmler-Harrison, Gail; Cruz, C. Russell; Lam, Sharon; Krance, Robert A.; Leung, Kathryn S.; Martinez, Caridad A.; Liu, Hao; Douek, Daniel C.; Heslop, Helen E.; Rooney, Cliona M.; Shpall, Elizabeth J.; Barrett, A. John; Bollard, Catherine M.

In: Science Translational Medicine, Vol. 7, No. 285, 285ra63, 29.04.2015.

Research output: Contribution to journalArticle

Hanley, PJ, Melenhorst, JJ, Nikiforow, S, Scheinberg, P, Blaney, JW, Demmler-Harrison, G, Cruz, CR, Lam, S, Krance, RA, Leung, KS, Martinez, CA, Liu, H, Douek, DC, Heslop, HE, Rooney, CM, Shpall, EJ, Barrett, AJ & Bollard, CM 2015, 'CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo', Science Translational Medicine, vol. 7, no. 285, 285ra63. https://doi.org/10.1126/scitranslmed.aaa2546
Hanley PJ, Melenhorst JJ, Nikiforow S, Scheinberg P, Blaney JW, Demmler-Harrison G et al. CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Science Translational Medicine. 2015 Apr 29;7(285). 285ra63. https://doi.org/10.1126/scitranslmed.aaa2546
Hanley, Patrick J. ; Melenhorst, Jan J. ; Nikiforow, Sarah ; Scheinberg, Phillip ; Blaney, James W. ; Demmler-Harrison, Gail ; Cruz, C. Russell ; Lam, Sharon ; Krance, Robert A. ; Leung, Kathryn S. ; Martinez, Caridad A. ; Liu, Hao ; Douek, Daniel C. ; Heslop, Helen E. ; Rooney, Cliona M. ; Shpall, Elizabeth J. ; Barrett, A. John ; Bollard, Catherine M. / CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. In: Science Translational Medicine. 2015 ; Vol. 7, No. 285.
@article{750639f8b00f41579cae331612802e22,
title = "CMV-specific T cells generated from na{\"i}ve T cells recognize atypical epitopes and may be protective in vivo",
abstract = "Adoptive transfer of cytomegalovirus (CMV)-specific T cells derived from adult seropositive donors can effectively restore antiviral immunity after transplantation. However, CMV-seronegative donors lack CMV-specific memory T cells, which restricts the availability of virus-specific T cells for immunoprophylaxis. We demonstrate the feasibility of deriving CMV-specific T cells from na{\"i}ve cells for T cell therapy. Na{\"i}ve T cells primed to recognize CMV were restricted to different, atypical epitopes than T cells derived from CMV-seropositive individuals; however, these two cell populations had similar avidities. CMV-seropositive individuals also had T cells recognizing these atypical epitopes, but these cells had a lower avidity than those derived from the seronegative subjects, which suggests that high-avidity T cells to these epitopes may be lost over time. Indeed, recipients of cord blood (CB) grafts who did not develop CMV were found by clonotypic analysis to have T cells recognizing atypical CMVpp65 epitopes. Therefore, we examined unmanipulated CB units and found that T cells with T cell receptors restricted by atypical epitopes were the most common, which may explain why these T cells expanded. When infused to recipients, na{\"i}ve donor-derived virus-specific T cells that recognized atypical epitopes were associated with prolonged periods of CMV-free survival and complete remission. These data suggest that na{\"i}ve-derived T cells from seronegative patients may be an additional source of cells for CMV immunoprophylaxis.",
author = "Hanley, {Patrick J.} and Melenhorst, {Jan J.} and Sarah Nikiforow and Phillip Scheinberg and Blaney, {James W.} and Gail Demmler-Harrison and Cruz, {C. Russell} and Sharon Lam and Krance, {Robert A.} and Leung, {Kathryn S.} and Martinez, {Caridad A.} and Hao Liu and Douek, {Daniel C.} and Heslop, {Helen E.} and Rooney, {Cliona M.} and Shpall, {Elizabeth J.} and Barrett, {A. John} and Bollard, {Catherine M.}",
year = "2015",
month = "4",
day = "29",
doi = "10.1126/scitranslmed.aaa2546",
language = "English (US)",
volume = "7",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "285",

}

TY - JOUR

T1 - CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

AU - Hanley, Patrick J.

AU - Melenhorst, Jan J.

AU - Nikiforow, Sarah

AU - Scheinberg, Phillip

AU - Blaney, James W.

AU - Demmler-Harrison, Gail

AU - Cruz, C. Russell

AU - Lam, Sharon

AU - Krance, Robert A.

AU - Leung, Kathryn S.

AU - Martinez, Caridad A.

AU - Liu, Hao

AU - Douek, Daniel C.

AU - Heslop, Helen E.

AU - Rooney, Cliona M.

AU - Shpall, Elizabeth J.

AU - Barrett, A. John

AU - Bollard, Catherine M.

PY - 2015/4/29

Y1 - 2015/4/29

N2 - Adoptive transfer of cytomegalovirus (CMV)-specific T cells derived from adult seropositive donors can effectively restore antiviral immunity after transplantation. However, CMV-seronegative donors lack CMV-specific memory T cells, which restricts the availability of virus-specific T cells for immunoprophylaxis. We demonstrate the feasibility of deriving CMV-specific T cells from naïve cells for T cell therapy. Naïve T cells primed to recognize CMV were restricted to different, atypical epitopes than T cells derived from CMV-seropositive individuals; however, these two cell populations had similar avidities. CMV-seropositive individuals also had T cells recognizing these atypical epitopes, but these cells had a lower avidity than those derived from the seronegative subjects, which suggests that high-avidity T cells to these epitopes may be lost over time. Indeed, recipients of cord blood (CB) grafts who did not develop CMV were found by clonotypic analysis to have T cells recognizing atypical CMVpp65 epitopes. Therefore, we examined unmanipulated CB units and found that T cells with T cell receptors restricted by atypical epitopes were the most common, which may explain why these T cells expanded. When infused to recipients, naïve donor-derived virus-specific T cells that recognized atypical epitopes were associated with prolonged periods of CMV-free survival and complete remission. These data suggest that naïve-derived T cells from seronegative patients may be an additional source of cells for CMV immunoprophylaxis.

AB - Adoptive transfer of cytomegalovirus (CMV)-specific T cells derived from adult seropositive donors can effectively restore antiviral immunity after transplantation. However, CMV-seronegative donors lack CMV-specific memory T cells, which restricts the availability of virus-specific T cells for immunoprophylaxis. We demonstrate the feasibility of deriving CMV-specific T cells from naïve cells for T cell therapy. Naïve T cells primed to recognize CMV were restricted to different, atypical epitopes than T cells derived from CMV-seropositive individuals; however, these two cell populations had similar avidities. CMV-seropositive individuals also had T cells recognizing these atypical epitopes, but these cells had a lower avidity than those derived from the seronegative subjects, which suggests that high-avidity T cells to these epitopes may be lost over time. Indeed, recipients of cord blood (CB) grafts who did not develop CMV were found by clonotypic analysis to have T cells recognizing atypical CMVpp65 epitopes. Therefore, we examined unmanipulated CB units and found that T cells with T cell receptors restricted by atypical epitopes were the most common, which may explain why these T cells expanded. When infused to recipients, naïve donor-derived virus-specific T cells that recognized atypical epitopes were associated with prolonged periods of CMV-free survival and complete remission. These data suggest that naïve-derived T cells from seronegative patients may be an additional source of cells for CMV immunoprophylaxis.

UR - http://www.scopus.com/inward/record.url?scp=84929493070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929493070&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aaa2546

DO - 10.1126/scitranslmed.aaa2546

M3 - Article

C2 - 25925682

AN - SCOPUS:84929493070

VL - 7

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 285

M1 - 285ra63

ER -